Sutro Biopharma Inc.
STRO | NASDAQ
$16.31
-$0.04 (-0.24%)
Sep 22, 2026, 12:30 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.51 | -0.62 | -2.41 | -3.44 | -6.50 | -21.93 |
PEG Ratio | 0.02 | -0.01 | 0.10 | -1.31 | -0.05 | 0.37 |
PS Ratio | 0.96 | 2.28 | 1.68 | 6.05 | 11.09 | 16.55 |
PB Ratio | -0.74 | 3.17 | 1.72 | 1.89 | 2.72 | 2.13 |
P/FCF Ratio | -0.55 | -0.73 | -2.23 | -95.14 | -7.07 | -9.44 |
P/OCF Ratio | -0.55 | -0.74 | -2.31 | 115.52 | -8.40 | -10.43 |
OCF/S Ratio | -172.94 | -308.72 | -72.60 | 5.24 | -132 | -158.71 |
Debt / Equity Ratio | -0.12 | 0.52 | 0.22 | 0.25 | 0.23 | 0.07 |
Quick Ratio | 2.01 | 2.60 | 4.50 | 5.31 | 5.24 | 12.78 |
Current Ratio | 2.01 | 2.60 | 4.50 | 5.31 | 5.24 | 12.78 |
Asset Turnover | 0.59 | 0.16 | 0.33 | 0.17 | 0.18 | 0.11 |
Interest Coverage | -2.75 | -7.67 | -3.76 | -38.54 | -31.41 | -17.88 |
Return on Equity | 144.27% | -509.99% | -71.36% | -54.92% | -41.79% | -9.68% |
Return on Assets | -109.93% | -58.74% | -22.69% | -29.29% | -30.91% | -8.15% |
Return on Invested Capital | -98.52% | -90.74% | -23.04% | -35.61% | -31.77% | -19.49% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 92.85% | 88.37% | 95.57% | 87.77% | 84.21% | -80.14% |
Net Profit Margin | -186.45% | -366.62% | -69.47% | -175.89% | -170.55% | -75.20% |
Pretax Profit Margin | -186.55% | -362.81% | -57.63% | -172.20% | -170.55% | -75.20% |
Operating Profit Margin | -102.41% | -384.34% | -58.07% | -190.26% | -159.22% | -166.32% |
FCF Margin | -174.59% | -313.71% | -75.41% | -6.36% | -156.76% | -175.39% |
EBITDA Margin | -142.12% | -290.85% | -44.18% | -155.03% | -157.66% | -55.60% |
Add to Watchlist
Select watchlists to add or remove STRO